Gut Microbiome and Risk of Dementia - a Prospective, Population-Based Study
Tynkkynen, J.; Kambur, Oleg, O.; Niiranen, T.; Lahti, L.; Ruuskanen, M. O.; McDonald, D.; Jousilahti, P.; Gazolla Volpiano, C.; Meric, G.; Inouye, M.; Liu, Y.; Khatib, L.; Patel, L.; Salomaa, V.; Knight, R.; Havulinna, A.
Show abstract
INTRODUCTIONThe pathophysiology and risk factors for Alzheimers disease (AD) and dementia are insufficiently known. We studied the connections between gut microbiome, overall dementia and AD in a prospective, population-based cohort. METHODSWe followed a population based random sample of 4,055 individuals (FINRISK 2022) for 16 years, with 330 cases of incident dementia and 280 AD cases. Gut microbiome community diversity and composition were assessed against future dementia and AD risk. Competing mortality risks were accounted for using Fine-Gray models. RESULTSCommunity diversity was not associated with dementia or AD. However, a supervised ordination with dbRDA suggested a possible compositional link between gut microbiome and dementia. One putative bacterial genus, Dorea, was associated with a decreased dementia risk. APOE {varepsilon}4 genotype associated with several taxa; of these, phylum Verrucomicrobiota and species Nocardia carnea were associated with incident dementia. DISCUSSIONThe gut-brain axis has a modest association on future dementia or AD risk. Microbial composition, rather diversities, may contribute to dementia risk.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Interrogating the plasma proteome of repetitive head impact exposure and chronic traumatic encephalopathy 94%
- Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer’s disease 93%
- Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain 93%
Similar papers in this journal
- Probing Gut-Brain Links in Alzheimer’s Disease with Rifaximin 95%
- Genetic and Multi-omic Risk Assessment of Alzheimer’s Disease Implicates Core Associated Biological Domains 92%
- Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: modification by genetic risk for Alzheimer’s disease 90%
Similar papers in this journal
Similar papers in this journal
- Integrative Brain Transcriptome Analysis Links Complement Component 4 and HSPA2 to the APOE ε2 Protective Effect in Alzheimer Disease 94%
- Peripheral innate immunophenotype in neurodegenerative disease: blood-based profiles and links to survival 94%
- African Ancestry GWAS of Dementia in a Large Military Cohort Identifies Significant Risk Loci 94%